Evidence map›Paper›PMID 25120785›Full record

ArticleInternational journal of clinical and experimental pathology2014

Dynamic metabolites profile of cerebral ischemia/reperfusion revealed by (1)H NMR-based metabolomics contributes to potential biomarkers.

Yun Wang, Yi-Gang Wang, Teng-Fei Ma, Mei Li, Shu-Ling Gu

Abstract read
In one paragraph

Article in International journal of clinical and experimental pathology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Corroborated evidence on change of metabolome after ischemic stroke due to large vessel occlusion.Metabolomics : Official journal of the Metabolomic Society · 2025
    Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Yun WangKey Laboratory of Target Drug and Clinical Application, Department of Pharmacology, Xuzhou Medical College Xuzhou, Jiangsu, China.
Yi-Gang WangKey Laboratory of Target Drug and Clinical Application, Department of Pharmacology, Xuzhou Medical College Xuzhou, Jiangsu, China ; 215 Hospital of Shannxi Nuclear Industry Xianyang, Shannxi, China.
Teng-Fei MaKey Laboratory of Target Drug and Clinical Application, Department of Pharmacology, Xuzhou Medical College Xuzhou, Jiangsu, China.
Mei LiKey Laboratory of Target Drug and Clinical Application, Department of Pharmacology, Xuzhou Medical College Xuzhou, Jiangsu, China.
Shu-Ling GuKey Laboratory of Target Drug and Clinical Application, Department of Pharmacology, Xuzhou Medical College Xuzhou, Jiangsu, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Current metabolomic studies of ischemic brain mainly attach importance on a certain ischemic period, are lack of data about dynamic metabolites in ischemic stroke process, especially early period. Thus, in this study, (1)H NMR spectroscopy was used to investigate biochemical changes in the early stages of rats' focal cerebral ischemia reperfusion (I/R) injury. Serum samples of 0, 0.5, 1, 3, 6, 12, 24 h of reperfusion, based on multivariate data analyses, were tested to analyze the changing of metabolites during the early disease process. Partial least squares-discriminant analysis scores plots of the (1)H NMR data revealed clear differences among the experiment groups. Combination the results of loading plot and t-test, we found that 13 metabolites were changed significantly. Among that, malonic acid and glycine are the most noticeable variable metabolites. Dramatic changed malonic acid and glycine most probably served as biomarkers in this study. These findings help us understand the biochemical metabolite changes in early ischemic stroke stages, especially different periods. That may be conducive to distinguish at-risk individuals, benefit early diagnosis and understand the dynamic pathogenesis of early cerebral ischemia.

Indexed as

AnimalsBiomarkersBrain IschemiaDisease Models, AnimalGlycineMagnetic Resonance SpectroscopyMaleMalonatesMetabolomicsRatsRats, Sprague-DawleyReperfusion InjuryStrokeBiomarkersGlycineMalonatesmalonic acidbiomarkersglycineischemic strokemalonic acidMetabolomic

Identifiers

PMID25120785
PMCPMC4129020

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.